Bioplatforms Australia
  • Platforms
    • Genomics
    • Proteomics
    • Metabolomics
    • Synthetic Biology
    • Multiomics Network
    • Bioinformatics
  • Missions
    • Agriculture & Food
    • Biodiversity & Environment
    • Human Health
  • Initiatives
  • Partnerships
  • Translation
  • About
    • About Us
    • NCRIS
    • Board
    • Team Contacts
    • News
  • Data Portal
Select Page
AlphaFold: transforming protein research for Australian scientists

AlphaFold: transforming protein research for Australian scientists

by Aude Touffu | Jan 28, 2025 | Agriculture and Food, Biodiversity and Environment, Human Health

The 2024 Nobel Prize in Chemistry was awarded to the team behind the transformative AI tool AlphaFold. In a major achievement for life sciences and biomedical research, the tool developed by DeepMind and released in 2020 enables rapid, accurate prediction of protein...
Annual Report 2024

Annual Report 2024

by Aude Touffu | Nov 26, 2024 | Agriculture and Food, Biodiversity and Environment, Human Health

Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability...
EMBL Australia joins NCRIS Health Group to enhance collaborative health research

EMBL Australia joins NCRIS Health Group to enhance collaborative health research

by Aude Touffu | Oct 28, 2024 | Human Health

EMBL Australia has signed a Memorandum of Understanding (MOU) to join the NCRIS Health Group, strengthening Australian collaborative health research.  The NCRIS Health Group, supported by the Australian Government’s National Collaborative Research Infrastructure...
Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease

Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease

by Aude Touffu | Sep 10, 2024 | Human Health

Proteomics International Laboratories has released a groundbreaking study showing that its PromarkerD predictive test can effectively forecast renal decline in patients with type 1 diabetes. This exciting development, presented at the recent Australasian Diabetes...
Pioneering Australian vaccine innovation in the wake of Covid-19

Pioneering Australian vaccine innovation in the wake of Covid-19

by Aude Touffu | Aug 19, 2024 | Human Health

The emergence of COVID-19 and the ensuing pandemic have demonstrated the ongoing threat that infectious diseases pose to our health, economy, and lifestyle. While traditional vaccines often take years to develop, the urgency of the pandemic has redefined expectations,...
Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform

Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform

by Aude Touffu | Aug 18, 2024 | Human Health

To bring new therapeutics into clinical use, understanding their mechanisms of action is essential. However, many drug candidates identified through phenotypic screening do not have known targets. To overcome this challenge, the Australian drug discovery landscape...
Page 1 of 612345...»Last »

GET IN TOUCH

PHONE

P: +61 410 538 648
F: +61 2 9850 6200

 

CONTACT US

See team details here.

 

ABN

40 125 905 599

ADDRESS

Level 4, Building 4WW, Research Park Drive
Macquarie University, NSW 2019, Australia

  • Follow
  • Follow

Bioplatforms Australia is made possible through investment funding provided by the Commonwealth Government National Collaborative Research Infrastructure Strategy (NCRIS).